FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC

Clinical trial NCT06403111 · RECRUITING

Trial details

NCT number: NCT06403111
Sponsor: Changzhou No.2 People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2024-06-01
Primary completion: 2026-06-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.